Amiloxate
Names | |
---|---|
IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)acrylate | |
Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate | |
Identifiers | |
71617-10-2 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL1476782 |
ChemSpider | 1266578 |
ECHA InfoCard | 100.068.798 |
PubChem | 1549789 |
| |
| |
Properties | |
C15H20O3 | |
Molar mass | 248.32 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]
See also
References
- ↑ Brian Palmer. "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
- ↑ Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News. 92 (19): 27.
This article is issued from Wikipedia - version of the 7/7/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.